UnitedHealth Group Incorporated $UNH Shares Sold by Ninety One North America Inc.

Ninety One North America Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,204 shares of the healthcare conglomerate’s stock after selling 400 shares during the quarter. Ninety One North America Inc.’s holdings in UnitedHealth Group were worth $688,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Rogco LP boosted its holdings in UnitedHealth Group by 22.1% in the second quarter. Rogco LP now owns 2,032 shares of the healthcare conglomerate’s stock valued at $634,000 after purchasing an additional 368 shares in the last quarter. Pacific Point Advisors LLC grew its position in shares of UnitedHealth Group by 30.0% during the second quarter. Pacific Point Advisors LLC now owns 5,145 shares of the healthcare conglomerate’s stock worth $1,605,000 after acquiring an additional 1,187 shares during the last quarter. Community Bank & Trust Waco Texas raised its position in UnitedHealth Group by 0.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 13,910 shares of the healthcare conglomerate’s stock valued at $4,340,000 after purchasing an additional 44 shares during the last quarter. Provident Wealth Management LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $216,000. Finally, PFG Investments LLC raised its holdings in shares of UnitedHealth Group by 36.1% in the second quarter. PFG Investments LLC now owns 11,793 shares of the healthcare conglomerate’s stock valued at $3,679,000 after buying an additional 3,127 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.0%

Shares of UnitedHealth Group stock opened at $345.11 on Wednesday. The company has a 50-day moving average of $303.65 and a two-hundred day moving average of $357.64. The stock has a market cap of $312.56 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 2.25 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Morgan Stanley boosted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. KeyCorp cut their price target on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.